- E34.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E34.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E34.0 – other international versions of ICD-10 E34.0 may differ.
ICD-10-CM E34.0 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E34.0:
- syndrome > Argentaffinoma
- by > hormone E22.2
- carcinoid tumor > by E34.0
- argentaffin, argintaffinoma > Syndrome
- Björck (-Thorsen) > Syndrome
- carcinoid > Syndrome
- Cassidy (-Scholte) > Syndrome
- flush > Syndrome
- Hedinger\’s > Syndrome
- intestinal > Syndrome
- carcinoid > intestinal E34.0
- malignant > Syndrome
- carcinoid > malignant E34.0
- metastatic carcinoid > Syndrome
- Scholte\’s > Syndrome
- Thorson-Björck > Syndrome